Icahn School of Medicine at Mount Sinai
Hospital / Contact Us / Visiting Us / Levy Library / Alumni / Careers / Make A Gift / Find A Faculty
go button image
Mount Sinai - Facebook Mount Sinai - TwitterMount Sinai - YouTubeMount Sinai - Google+Mount Sinai Blog
  • About The School
    • Dean's Office
    • Diversity
    • Quick Facts
    • For Faculty
    • Visiting Us
    • News and Events
    • Alumni
    • Contact Us
    • Media Contacts
    • Hess Center
    • SinaInnovations
  • Education
    • Medical Education
    • Graduate School
    • Residencies & Fellowships
    • Continuing Medical Education
    • Student Life and Resources
    • Office of Postdoctoral Affairs
    • Center for Multicultural & Community Affairs
    • Bioethics
    • Mount Sinai Global Health
    • Institute for Medical Education
    • Enrollment and Orientation
  • Patient Care
    • Find a Doctor
    • Faculty Practice
  • Research
    • Institutes
    • Centers
    • Programs
    • Laboratories
    • Grant Application Resource Center
    • Clinical Trials
    • SINAInnovations
    • Resources
  • Departments & Institutes

Home > Research > Laboratories > The Pathogenesis of Glomerular Scarring – Novel Pathways in Kidney Podocytes
Share

The Pathogenesis of Glomerular Scarring – Novel Pathways in Kidney Podocytes

  • About Us
  • Team
  • Projects and Grants
  • Recognition and Publications

About Us

Our laboratory is focused on identifying and characterizing novel pathways in the kidney podocyte that are critical to the pathogenesis of glomerulosclerosis. Read More

SCHOOL OF MEDICINE NEWS

Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 
May 24, 2013 - The new agreement was negotiated through Blue Mountain Technologies, a program of Mount Sinai Innovation Partners.

 

Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 
May 22, 2013 - Partnership will accelerate the pace of discovery and innovation in Biomedical Sciences.

 

Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression 
May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.

 
VIEW ALL

Lewis Kaufman, MD

Contact Us

Lewis Kaufman, MD
Tel: 212-241-6271
Fax: 212-987-0989
Send email

1468 Madison Avenue
Box 1243
Annenberg Building
23rd Floor, Room 23-76 (Lab)
New York, NY 10029

Affiliations
Department of Medicine Division of Nephrology
Careers |Contact Us |Privacy |Legal
212-241-6500
© 2013 The Mount Sinai Hospital